Abstract
Background: This is the first study to evaluate the efficacy and safety of transcranial pulse stimulation (TPS) for the treatment of attention-deficit/hyperactivity disorder (ADHD) among young adolescents in Hong Kong. Methods: This double-blind, randomized, sham-controlled trial included a TPS group and a sham TPS group, encompassing a total of 30 subjects aged 12–17 years who were diagnosed with ADHD. Baseline measurements SNAP-IV, ADHD RS-IV, CGI and executive functions (Stroop tests, Digit Span) and post-TPS evaluation were collected. Both groups were assessed at baseline, immediately after intervention, and at 1-month and 3-month follow-ups. Repeated-measures ANOVAs were used to analyze data. Results: The TPS group exhibited a 30% reduction in the mean SNAP-IV score at postintervention that was maintained at 1- and 3-month follow-ups. Conclusion: TPS is an effective and safe adjunct treatment for the clinical management of ADHD. Clinical trial registration: ClinicalTrials.Gov, identifier NCT05422274.
Original language | English |
---|---|
Article number | 1364270 |
Pages (from-to) | 1-16 |
Number of pages | 16 |
Journal | Frontiers in Neurology |
Volume | 15 |
DOIs | |
Publication status | Published - 9 May 2024 |
Keywords
- ADHD
- adolescents
- efficacy
- neuromodulation
- rct
- transcranial pulse stimulation
ASJC Scopus subject areas
- Neurology
- Clinical Neurology